BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32045366)

  • 1. Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis.
    Park SH; Kang MA; Moon YJ; Jang KY; Kim JR
    Aging (Albany NY); 2020 Feb; 12(6):4727-4741. PubMed ID: 32045366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of l-thyroxine to differentiate osteoblast-like cells via Angiopoietin1.
    Park SH; Lee J; Kang MA; Moon YJ; Wang SI; Kim KM; Park BH; Jang KY; Kim JR
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1409-15. PubMed ID: 27569283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knee loading protects against osteonecrosis of the femoral head by enhancing vessel remodeling and bone healing.
    Liu D; Li X; Li J; Yang J; Yokota H; Zhang P
    Bone; 2015 Dec; 81():620-631. PubMed ID: 26416150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model.
    Kuroyanagi G; Adapala NS; Yamaguchi R; Kamiya N; Deng Z; Aruwajoye O; Kutschke M; Chen E; Jo C; Ren Y; Kim HKW
    Bone; 2018 Nov; 116():221-231. PubMed ID: 30125727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol induces osteoblast differentiation via angiopoietin1 and p38 MAPK.
    Kang MA; Lee J; Park SH
    Environ Toxicol; 2020 Dec; 35(12):1318-1325. PubMed ID: 32656944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased matrix mineralization in the immature femoral head following ischemic osteonecrosis.
    Hofstaetter JG; Roschger P; Klaushofer K; Kim HK
    Bone; 2010 Feb; 46(2):379-85. PubMed ID: 19833243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
    Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
    Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
    Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
    Zhang J; Park J; Lee JW; Kwon YD; Kim EC
    Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials.
    Bejar J; Peled E; Boss JH
    Theor Biol Med Model; 2005 Jul; 2():24. PubMed ID: 15996271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
    Huang J; Yuan L; Wang X; Zhang TL; Wang K
    Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity.
    Patel JJ; Butters OR; Arnett TR
    Cell Biochem Funct; 2014 Jun; 32(4):368-77. PubMed ID: 24615887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a mouse model of ischemic osteonecrosis.
    Kamiya N; Yamaguchi R; Aruwajoye O; Adapala NS; Kim HK
    Clin Orthop Relat Res; 2015 Apr; 473(4):1486-98. PubMed ID: 25666143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metformin on alveolar bone in ligature-induced periodontitis in rats: a pilot study.
    Bak EJ; Park HG; Kim M; Kim SW; Kim S; Choi SH; Cha JH; Yoo YJ
    J Periodontol; 2010 Mar; 81(3):412-9. PubMed ID: 20192868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
    Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
    J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin alleviates hyperglycemia-induced apoptosis and differentiation suppression in osteoblasts through inhibiting the TLR4 signaling pathway.
    Zheng L; Shen X; Ye J; Xie Y; Yan S
    Life Sci; 2019 Jan; 216():29-38. PubMed ID: 30414431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts.
    Zhang T; Han W; Zhao K; Yang W; Lu X; Jia Y; Qin A; Qian Y
    FASEB J; 2019 Apr; 33(4):5399-5410. PubMed ID: 30702934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity - an in vitro mechanism study for preventing destructive repair of osteonecrosis.
    Cao HJ; Zheng LZ; Wang N; Wang LY; Li Y; Li D; Lai YX; Wang XL; Qin L
    Bone; 2015 May; 74():58-68. PubMed ID: 25554601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts.
    Chen X; Zhu G; Jin T; Zhou Z; Gu S; Qiu J; Xiao H
    Biol Trace Elem Res; 2012 Jun; 146(3):349-53. PubMed ID: 22076734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.